Methotrexate tablets

DRUG5 trials

Sponsors

Shanghai Zhongshan Hospital, Diakonhjemmet Hospital, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Quan Jiang, Yancheng First People's Hospital

Conditions

Erosive OsteoarthritisHand OsteoarthritisInhibitionMethotrexateRheumatoid ArthritisSolid TumorsTakayasu ArteritisTreatment

Phase 1

A Clinical Trial of Safety and Tolerance of TQH3821 Tablets in Adult Healthy Subjects

CompletedNCT05380934

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Rheumatoid Arthritis

Start: 2022-05-29End: 2023-05-20Updated: 2024-01-22

Phase 2

Methotrexate Combined With Immunotherapy During Radiotherapy for Solid Tumors

Active, not recruitingNCT05522582

Yancheng First People's HospitalSolid Tumors

Start: 2021-11-15End: 2026-12-31Target: 50Updated: 2024-10-26

Phase 4

Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients

Shanghai Zhongshan HospitalInhibition, Methotrexate, Takayasu Arteritis +1

Start: 2020-03-01End: 2023-12-31Target: 130Updated: 2020-06-12

Methotrexate in Erosive Inflammatory Hand Osteoarthritis

Active, not recruitingNCT04579848

Diakonhjemmet HospitalErosive Osteoarthritis, Hand Osteoarthritis

Start: 2021-08-12End: 2026-12-31Target: 163Updated: 2025-12-19

Efficacy and Safety of Colquhounia Root Tablet in Patients With Rheumatoid Arthritis

Quan JiangRheumatoid Arthritis

Start: 2022-07-31End: 2024-06-30Target: 120Updated: 2022-07-08

Related Papers

Protocol for the MERINO study: A randomized placebo-controlled trial assessing the efficacy, safety, and cost-effectiveness of methotrexate in people with erosive hand osteoarthritis.

2024-12-15